PAREXEL® Access eHub:

Value Through Evidence

Back to Content Hub

Delivering data that supports your value argument

If you’re a small biotech firm looking for a sale to a large pharmaceutical company, data could make the difference between investment and rejection. By adopting a similar commercial framework to large pharma companies you can prove value and peak interest in your product.

Smaller biotech companies are typically more science-minded and sometimes lose sight of the end commercialization goal. For large pharmaceutical companies however, reimbursement is front-of-mind when considering a new drug. 


Small biotech companies need to consider: 

• Due diligence 

• Commercial analysis 

• Risk vs return for a big pharma company 

White Paper: The Buyer is Aware: Delivering Data That Supports Your Commercial Value Argument

Share this: